4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-064025
President and CEO sold 24,337 shares at $9.37 ($228,026)
- President and CEO acquired 89,337 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chan Phillip P. President and CEO | 2018-12-07 | Option exercise | +89,337 | $2.10 | $187,608 | 527,618 | D: show line 1 in the form |
| Chan Phillip P. President and CEO | 2018-12-07 | Sale | −24,337 | $9.37 | $228,026 | 503,281 | D: show line 2 in the form |
| Open-market sales · 24,337 sh · avg $9.37 · $228,026 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chan Phillip P. President and CEO | 2018-12-07 | Option exercise · Non-Statutory Stock Option (right to buy) | +89,337 | 0 | D: show line 3 in the form |
Loading xslF345X03/tv508949_4.xml…